MX373099B - Polisacárido de ácido poligulónico sulfatado o sal farmacéutica del mismo, método de preparación del mismo y su uso. - Google Patents

Polisacárido de ácido poligulónico sulfatado o sal farmacéutica del mismo, método de preparación del mismo y su uso.

Info

Publication number
MX373099B
MX373099B MX2016000043A MX2016000043A MX373099B MX 373099 B MX373099 B MX 373099B MX 2016000043 A MX2016000043 A MX 2016000043A MX 2016000043 A MX2016000043 A MX 2016000043A MX 373099 B MX373099 B MX 373099B
Authority
MX
Mexico
Prior art keywords
inhibitors
preparation
pharmaceutical salt
acid polysaccharide
polygulonic acid
Prior art date
Application number
MX2016000043A
Other languages
English (en)
Spanish (es)
Other versions
MX2016000043A (es
Inventor
Jian Ding
Jing Ai
Xun Huang
Yi Chen
Original Assignee
Shanghai Inst Materia Medica Cas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Inst Materia Medica Cas filed Critical Shanghai Inst Materia Medica Cas
Publication of MX2016000043A publication Critical patent/MX2016000043A/es
Publication of MX373099B publication Critical patent/MX373099B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
MX2016000043A 2013-07-02 2014-07-02 Polisacárido de ácido poligulónico sulfatado o sal farmacéutica del mismo, método de preparación del mismo y su uso. MX373099B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201310275323.7A CN104277130A (zh) 2013-07-02 2013-07-02 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途
PCT/CN2014/081472 WO2015000411A1 (zh) 2013-07-02 2014-07-02 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途

Publications (2)

Publication Number Publication Date
MX2016000043A MX2016000043A (es) 2016-05-31
MX373099B true MX373099B (es) 2020-03-31

Family

ID=52143111

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016000043A MX373099B (es) 2013-07-02 2014-07-02 Polisacárido de ácido poligulónico sulfatado o sal farmacéutica del mismo, método de preparación del mismo y su uso.

Country Status (19)

Country Link
US (1) US10058566B2 (enExample)
EP (1) EP3018147B1 (enExample)
JP (2) JP6757249B2 (enExample)
KR (1) KR102258569B1 (enExample)
CN (2) CN104277130A (enExample)
AU (1) AU2014286711B2 (enExample)
BR (1) BR112015032849B1 (enExample)
CA (1) CA2916749C (enExample)
DK (1) DK3018147T3 (enExample)
EA (1) EA028655B1 (enExample)
ES (1) ES2674976T3 (enExample)
HU (1) HUE038981T2 (enExample)
MX (1) MX373099B (enExample)
PL (1) PL3018147T3 (enExample)
PT (1) PT3018147T (enExample)
SG (1) SG11201510717SA (enExample)
TR (1) TR201809674T4 (enExample)
WO (1) WO2015000411A1 (enExample)
ZA (1) ZA201509353B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104277130A (zh) * 2013-07-02 2015-01-14 中国科学院上海药物研究所 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途
CN107904240A (zh) * 2017-12-04 2018-04-13 辽东学院 一种抗肝癌细胞转移的抑制剂组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228231A1 (de) 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
JPH0625304A (ja) 1992-07-06 1994-02-01 Higeta Shoyu Co Ltd ガラクトサミン重合体硫酸化物及び該物質を 含有する抗ウイルス剤
CN1132209A (zh) 1995-03-27 1996-10-02 青岛海洋大学 一种新药多聚甘露糖醛酸硫酸盐
GB2317182B (en) 1996-09-11 2000-11-01 Johnson & Johnson Medical Sulfated polysaccharides and uses thereof in medical treatment
CN1473836A (zh) 2003-08-04 2004-02-11 中国海洋大学 还原端1位为羧基的古罗糖醛酸寡糖及其衍生物
CN1213071C (zh) * 2003-11-25 2005-08-03 中国海洋大学 一种古糖酯及其制备方法和应用
JP4897310B2 (ja) 2006-02-28 2012-03-14 理研食品株式会社 Ｌ−グルロン酸金属塩又はｄ−マンヌロン酸金属塩の製造方法
JP2008027767A (ja) 2006-07-21 2008-02-07 Aomori Prefecture 固体高分子電解質膜及び燃料電池
CN101691410B (zh) * 2009-09-18 2011-12-28 中国海洋大学 一种具有防治胰岛素抵抗作用的海洋寡糖铬配合物
RU2553348C2 (ru) 2010-03-10 2015-06-10 Айновобайолоджик, Инк. Продукт, содержащий глюкоманнан, ксантановую камедь и альгинат для лечения метаболических нарушений
CN102743409B (zh) 2012-06-18 2013-11-20 中国海洋大学 聚甘露糖醛酸丙酯硫酸盐在制备抗甲型h1n1流感病毒药物中的应用
CN104277130A (zh) * 2013-07-02 2015-01-14 中国科学院上海药物研究所 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途

Also Published As

Publication number Publication date
EA028655B1 (ru) 2017-12-29
AU2014286711A1 (en) 2016-02-04
EA201690123A1 (ru) 2016-07-29
CA2916749C (en) 2021-03-09
MX2016000043A (es) 2016-05-31
CA2916749A1 (en) 2015-01-08
ES2674976T3 (es) 2018-07-05
CN104277130A (zh) 2015-01-14
CN105358582B (zh) 2018-09-21
JP6772318B2 (ja) 2020-10-21
JP2016523301A (ja) 2016-08-08
US10058566B2 (en) 2018-08-28
HUE038981T2 (hu) 2018-12-28
BR112015032849B1 (pt) 2021-09-14
EP3018147B1 (en) 2018-05-23
SG11201510717SA (en) 2016-01-28
KR20160029817A (ko) 2016-03-15
TR201809674T4 (tr) 2018-07-23
JP6757249B2 (ja) 2020-09-16
KR102258569B1 (ko) 2021-05-28
ZA201509353B (en) 2017-08-30
AU2014286711B2 (en) 2018-05-10
HK1220984A1 (zh) 2017-05-19
US20160367591A1 (en) 2016-12-22
JP2019090056A (ja) 2019-06-13
EP3018147A1 (en) 2016-05-11
PT3018147T (pt) 2018-07-17
WO2015000411A1 (zh) 2015-01-08
PL3018147T3 (pl) 2018-10-31
EP3018147A4 (en) 2017-04-05
DK3018147T3 (en) 2018-07-23
CN105358582A (zh) 2016-02-24
BR112015032849A2 (pt) 2020-05-12

Similar Documents

Publication Publication Date Title
IL282352B (en) Methods for producing autologous t cells useful to treat b cell malignancies and other cancers and compositions thereof
HRP20181302T1 (hr) Terapija za obnavljanje mikrobiota (mrt), pripravci i postupci proizvodnje
CL2018000813A1 (es) Conjugados de anticuerpo-fármaco de pirrolobenzodiazepina y métodos de uso.
CR20160425A (es) Moléculas de anticuerpos que se unen a lag-3 y usos de las mismas
SI3021869T1 (sl) Postopki zdravljenja raka z uporabo antagonistov in inhibitorjev TIGIT, ki se vežejo na os PD-1
CL2015001985A1 (es) Compuestos de tiazolcarboxamidas y piridinacarboxamida, inhibidores de quinasa pim.
MX2016008448A (es) Conjugados de var2csa-farmaco.
SI3331915T1 (sl) Zaviralci kontrolnih točk za uporabo v zdravljenju rakov, ki se prenašajo s krvjo
DK3027208T3 (da) Cancerdiagnose og -terapi, der involverer cancerstamceller
NZ733055A (en) Anti-c10orf54 antibodies and uses thereof
MX378792B (es) Células hospederas modificadas y oligosacáridos híbridos para su uso en producción de bioconjugados.
EA201400178A1 (ru) Лечение рака молочной железы
MX391924B (es) Soluciones de glicosidos de esteviol.
MX373309B (es) Composiciones antibióticas de ceftolozano.
CL2015003738A1 (es) Formulación líquida estable de amg-416 (velcalcetida)
IL245811A0 (en) Pharmaceutical compositions with hydrating and lubricating activity
CO2017005732A2 (es) Compuestos de dihidropirimidin-2-ona y sus usos médicos
BR112017001888A2 (pt) formulações biológicas para instilação intravesical
UY34543A (es) Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica.
EA201691860A1 (ru) Пептидный медикамент в виде сухого порошка
HRP20182199T1 (hr) Kruti pripravci koji sadrže tofogliflozin i postupak za njihovu proizvodnju
HRP20200128T1 (hr) Pripreme za liječenje gd2 pozitivnog raka
MX390436B (es) Sistemas y metodos de hidratacion.
MX373099B (es) Polisacárido de ácido poligulónico sulfatado o sal farmacéutica del mismo, método de preparación del mismo y su uso.
UA116372C2 (uk) Частинки резинату фенілефрину

Legal Events

Date Code Title Description
FG Grant or registration